Aveen R Jalal
Overview
Explore the profile of Aveen R Jalal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dixon J, Wellington V, Elnima A, Savers A, Ferreras L, Jalal A, et al.
Drug Deliv Transl Res
. 2025 Mar;
PMID: 40072728
Topically applied therapies must not only be effective at the molecular level but also efficiently access the target site which can be on milli/centimetre-scales. This bottleneck is particularly inhibitory for...
2.
Fernandez-Rhodes M, Adlou B, Williams S, Lees R, Peacock B, Aubert D, et al.
J Extracell Biol
. 2024 Jun;
2(4):e85.
PMID: 38939692
Extracellular vesicles (EVs) have the potential to provide new insights into skeletal muscle (SM) physiology and pathophysiology. However, current isolation protocols often do not eliminate co-isolated components such as lipoproteins...
3.
Williams S, Jalal A, Lewis M, Davies O
J Tissue Eng
. 2023 Mar;
14:20417314231155114.
PMID: 36911574
Extracellular vesicles (EVs) continue to gain interest across the scientific community for diagnostic and therapeutic applications. As EV applications diversify, it is essential that researchers are aware of challenges, in...
4.
Eltaher H, Ferreras L, Jalal A, Dixon J
Biomater Adv
. 2022 Nov;
143:213177.
PMID: 36371970
Nanotechnologies are being increasingly applied as systems for peptide and nucleic acid macromolecule drug delivery. However systemic targeting of these, or efficient topical and localized delivery remains an issue. A...
5.
Jalal A, Dixon J
Front Bioeng Biotechnol
. 2020 Aug;
8:849.
PMID: 32850720
Developing non-viral gene therapy vectors that both protect and functionally deliver nucleic acid cargoes will be vital if gene augmentation and editing strategies are to be effectively combined with advanced...